Roche expands, adds jobs

Share this article:

Roche is taking on 500 new employees and is expanding its production capacity. The Swiss drug maker announced Monday that it was investing a total of $800 million across four locations over the next five years.

The company said in a statement that the expansions in Penzburg, Germany; Basel, Switzerland; and Vacaville and Oceanside, CA, are part of an efforts to support demand for biologics, such as Perjeta, as well as the antibody drug conjugate Kadcyla.

This may sound familiar: AstraZeneca announced Tuesday that, it, too was diving deeper into antibody drug conjugates through an acquisition and by purchasing an equity stake in an ADC-focused company.

This material may not be published, broadcast, rewritten or redistributed in any form without prior authorization. Your use of this website constitutes acceptance of Haymarket Media's Privacy Policy and Terms & Conditions